Gsa Capital Partners LLP Lexicon Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$1.3 - $3.58 $632,767 - $1.74 Million	-486,744 Reduced 62.4%	293,333 $703,000
Q4 2023 Feb 16, 2024	BUY	$1.0 - $1.53 $780,077 - $1.19 Million	780,077 New	780,077 $1.19 Million
Q1 2023 May 12, 2023	BUY	$1.99 - $2.68 $138,884 - $187,039	69,791 New	69,791 $169,000
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $583,152 - $1.03 Million	-300,594 Reduced 80.89%	71,004 $170,000
Q2 2022 Aug 09, 2022	BUY	$1.31 - $2.69 $184,834 - $379,545	141,095 Added 61.21%	371,598 $691,000
Q1 2022 May 11, 2022	BUY	$1.95 - $3.89 $387,934 - $773,880	198,941 Added 630.32%	230,503 $482,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $120,251 - $194,421	31,562 New	31,562 $124,000
Q1 2020 May 12, 2020	SELL	$1.8 - $4.28 $323,065 - $768,178	-179,481 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.16 - $5.15 $567,159 - $924,327	179,481 New	179,481 $745,000
Q3 2019 Nov 12, 2019	SELL	$1.2 - $6.66 $104,558 - $580,299	-87,132 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$5.35 - $7.11 $319,314 - $424,360	59,685 Added 217.46%	87,132 $548,000
Q1 2019 May 15, 2019	SELL	$4.36 - $7.94 $127,046 - $231,363	-29,139 Reduced 51.5%	27,447 $153,000
Q4 2018 Feb 12, 2019	SELL	$6.15 - $10.51 $110,700 - $189,180	-18,000 Reduced 24.13%	56,586 $376,000
Q3 2018 Nov 13, 2018	BUY	$10.32 - $13.06 $587,208 - $743,114	56,900 Added 321.72%	74,586 $796,000
Q2 2018 Aug 09, 2018	SELL	$7.8 - $13.69 $254,280 - $446,294	-32,600 Reduced 64.83%	17,686 $212,000
Q1 2018 May 11, 2018	SELL	$7.86 - $11.39 $187,068 - $271,082	-23,800 Reduced 32.12%	50,286 $431,000
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $204,341 - $286,124	23,300 Added 45.88%	74,086 $732,000
Q3 2017 Nov 20, 2017	BUY	$12.17 - $16.3 $618,065 - $827,811	50,786	50,786 $624,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account